RxDoctor Payments Data

Michael Swinyer

Medical · Salt Lake City, UTNPI 1790724847

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 95.0% of the total across 317 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 21 manufacturers, the largest accounting for just 23.0% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $1,650, 2.2 times the $759 reported in 2021. Among medical clinicians in UT with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$5,247in general payments, 2019–2025

Across 317 payments — averaging $16.55 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$1K
  • Novartis$728
  • Johnson & Johnson$497
  • UCB, Inc.$459
  • Arcutis Biotherapeutics, Inc.$319
  • LEO Pharma Inc.$317
  • plus $2K from 15 others

What the payments were for

  • Food & beverage$4,98495%
  • Education$2635%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$5,247 in reported general payments places this provider in the 90th percentile of 263 medical providers in Utah.

See all medical providers in Utah

Medicare billing

Part B allowed, 2024
$144,211
Medicare patients
719
Services billed
4,097

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Clobetasol Propionate109$3,848
Metronidazole66$3,431
Triamcinolone Acetonide212$1,928
Clindamycin Phosphate31$1,744
Betamethasone Dipropionate29$1,276
Fluorouracil13$1,226
Econazole Nitrate26$1,143
ValacyclovirValacyclovir Hcl42$999
Ketoconazole51$848
Mupirocin70$521
Cephalexin40$507
Spironolactone32$406
Minocycline Hcl13$327
Minoxidil23$238
Finasteride16$123

Paid to pharmacies, not to this prescriber.

Other medical in Salt Lake City

See the full list for Utah

Where these figures come from

Is this you, or does something look wrong? →